{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6544d335e5c88f0013553610/6a468b380069388b7abf996d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Understanding Obesity in the GLP-1 Era","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6544d335e5c88f0013553610/1783008022019-725fe355-4f61-4d27-bae1-4016323d4571.jpeg?height=200","description":"<p>Few areas of healthcare have changed as rapidly over the past three years as obesity medicine.</p><p><br></p><p>With medications such as semaglutide and tirzepatide transforming the conversation around obesity, Bruce revisits this insightful discussion with Professor Donal O'Shea and dietitian Aoife Hearne.</p><p><br></p><p>Rather than focusing solely on medication, this episode explores the biology of obesity, the importance of compassion in clinical practice, and why understanding obesity as a chronic disease changes how we think about prevention, treatment and long-term support.</p><p><br></p><p>The treatments may have evolved, but the need for evidence-based, person-centred care has not.</p><p><br></p><p><em>This episode forms part of the ISESA Podcast Summer Series: Exercise Beyond Sport - three conversations exploring the growing role of sport and exercise science within healthcare.</em></p>","author_name":"Bruce Wardrop"}